Cargando…
Two-step screening method to identify α-synuclein aggregation inhibitors for Parkinson’s disease
Parkinson’s disease is a neurodegenerative disease characterized by the formation of neuronal inclusions of α-synuclein in patient brains. As the disease progresses, toxic α-synuclein aggregates transmit throughout the nervous system. No effective disease-modifying therapy has been established, and...
Autores principales: | Hideshima, Makoto, Kimura, Yasuyoshi, Aguirre, César, Kakuda, Keita, Takeuchi, Toshihide, Choong, Chi-Jing, Doi, Junko, Nabekura, Kei, Yamaguchi, Keiichi, Nakajima, Kichitaro, Baba, Kousuke, Nagano, Seiichi, Goto, Yuji, Nagai, Yoshitaka, Mochizuki, Hideki, Ikenaka, Kensuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748996/ https://www.ncbi.nlm.nih.gov/pubmed/35013421 http://dx.doi.org/10.1038/s41598-021-04131-9 |
Ejemplares similares
-
Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson’s disease-related fibril polymorphism
por: Choong, Chi-Jing, et al.
Publicado: (2023) -
Alternative mitochondrial quality control mediated by extracellular release
por: Choong, Chi-Jing, et al.
Publicado: (2020) -
Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid
por: Kakuda, Keita, et al.
Publicado: (2019) -
Lipids as Trans-Acting Effectors for α-Synuclein in the Pathogenesis of Parkinson’s Disease
por: Ikenaka, Kensuke, et al.
Publicado: (2019) -
E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's disease
por: Sakai, Ryusuke, et al.
Publicado: (2019)